Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome
Background: Minimally invasive surfactant therapy (MIST) is a new mode of surfactant administration without intubation to spontaneously breathing preterm infants with respiratory distress syndrome (RDS). The aims of this study were to assess the feasibility, efficacy and safety of using MIST to give...
Saved in:
| Main Authors: | Xing-An Wang, Lih-Ju Chen, Shan-Ming Chen, Pen-Hua Su, Jia-Yuh Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-04-01
|
| Series: | Pediatrics and Neonatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S187595721930542X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
by: Nilgün Köksal, et al.
Published: (2009-12-01) -
Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia
by: Minji Heo, et al.
Published: (2020-08-01) -
Significance of surfactant proteins in respiratory distress syndrome in preterm infants
by: İ.A. Mirzayeva, et al.
Published: (2024-04-01) -
Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
by: Ozge Sürmeli-Onay, et al.
Published: (2012-06-01) -
Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
by: Christos Tsakalidis, et al.
Published: (2012-08-01)